Search - tctmd.com

Displaying 961 - 980 of 1755

Sort: Relevancy | Date

Presentation SIF 2019

Mixed Mitral and Aortic Valve Disease: Which One to Fix First?

Presenter: Brij Maini

March 30, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

Podcast Heart Sounds

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Michael O'Riordan

March 27, 2019

News Conference News EHRA 2019

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

Todd Neale

March 25, 2019

News Conference News ACC 2019

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Yael L. Maxwell

March 17, 2019

News Conference News ACC 2019

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

Michael O'Riordan

March 17, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Industry News

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

March 14, 2019

News Daily News

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

L.A. McKeown

March 13, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Daily News

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

Todd Neale

March 12, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

Signal of Aortic Stenosis Risk With Celecoxib

Michael O'Riordan

March 05, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

L.A. McKeown

February 14, 2019

Presentation JIM 2019

Complications in Trans-Catheter Valve and Structural Heart Disease Interventions

Presenter: Maurice Buchbinder

February 14, 2019

Presentation JIM 2019

Clinical scenario and context: STEMI patient with MV disease

Presenter: Carlo Tumscitz

February 13, 2019

Presentation JIM 2019

Clinical scenario and context: A stable patient with LM involvement and MV disease

Presenter: Gianluca Campo

February 13, 2019

Podcast Rox Heart Radio

TMVR - Where Do We Stand Today After COAPT and MITRA-FR, and What Does This Mean for Patients?

February 13, 2019

Advertisement

Mixed Mitral and Aortic Valve Disease: Which One to Fix First?

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

Top Stories in Cardiology: March 2019

CMS Coverage Plan Keeps Volume Requirements for Existing TAVR Programs but Lowers Bar for New Centers

Thromboembolic Risks High in Patients With A-fib, Valvular Disease

TAVR in Bicuspid Aortic Stenosis Safe, Feasible in Selected Real-World Patients

Low-Risk Trials Cement a Role for TAVR Alongside—or in Place of—Surgery

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

FDA approves new indication for valve repair device to treat certain heart failure patients with mitral regurgitation

HF Admissions Decline, Non-CV Hospitalizations Rise After TAVR

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

DOACs in Patients With Mitral Stenosis and A-fib: Analysis Suggests a Benefit

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Signal of Aortic Stenosis Risk With Celecoxib

TCTMD’s Top 10 Most Popular Stories for February 2019

Aortic Stenosis Staging System Validated in Real-World, All-Comers Cohort

Complications in Trans-Catheter Valve and Structural Heart Disease Interventions

Clinical scenario and context: STEMI patient with MV disease

Clinical scenario and context: A stable patient with LM involvement and MV disease

TMVR - Where Do We Stand Today After COAPT and MITRA-FR, and What Does This Mean for Patients?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content